Myriad Genetics
Price & Volume
Stats
See more52W Range | $14.72-$29.30 |
Market Cap | $1.3B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $823.6M |
Revenue Growth (YoY) | 11.2% |
Gross Profit (12 Mos) | $476.4M |
Diluted EPS | -$1.28 |
News
See moreYahoo Finance • last month
Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer
Yahoo Finance • 2 months ago
Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
Yahoo Finance • 3 months ago
Insider Sale at Myriad Genetics Inc (MYGN): SVP, Chief of Staff Margaret Ancona Sells Shares
Yahoo Finance • 3 months ago
Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
About
CEO | Mr. Paul J. Diaz J.D. |
Address | 322 North 2200 West, Salt Lake City, UT, United States, 84116 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 2,700 |
